Parimi, S. et al. 2018. Pain response in a population-based study of radium-223 (Ra223) for metastatic castration-resistant prostate cancer. Canadian Urological Association Journal. 13, 10 (Dec. 2018), E311–6. DOI:https://doi.org/10.5489/cuaj.5685.